Bron TI, Bijlenga D, Verduijn J, et al. Prevalence of ADHD symptoms across clinical stages of major depressive disorder. J Affect Disord 2016; 197: 29–35.
Cha DS, Carvalho AF, Rosenblat JD, et al. Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer’s disease. CNS Neurol Disord Drug Targets 2014; 13 (10): 1740–1749.
Chen R, Hu Z, Wei L, et al. Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. Br J Psychiatry 2008; 193 (5): 373–377.
Gan Y, Gong Y, Tong Y, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371.
Jia Y, Li F, Liu YF, et al. Depression and cancer risk: a systematic review and meta-analysis. Public Health 2017; 149: 138–148.
Kessler RC. The prevalence of psychiatric comorbidity. In: Wetzler S, Sanderson WC (eds). An Einstein Psychiatry Publication, No. 14. Treatment Strategies for Patients with Psychiatric Comorbidity. John Wiley & Sons Inc. 1997.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31 (12): 2383–2390.
Rickelt J, Viechtbauer W, Lieverse R, et al. The relation between depressive and obsessive–compulsive symptoms in obsessive–compulsive disorder: results from a large, naturalistic follow-up study. J Affect Disord 2016; 203: 241–247.
Thaipisuttikul P, Ittasakul P, Waleeprakhon P, et al. Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat 2014; 10: 2097–2103.
Wu EL, Chien IC, Lin CH, et al. Increased risk of hypertension in patients with major depressive disorder: a population-based study. J Psychosom Res 2012; 73 (3): 169–174.